Russian Federation

This country profile was developed in collaboration with national authorities, the WHO Liaison Office for the Russian Federation and
the WHO Regional Office for Europe.

For further information please contact: WHO HIV helpdesk, Email: HIVhelpdesk@who.int, Tel: +41 22 791 1565, Fax: +41 22 791 1575,
www.who.int/hiv

Ik zal eens mailen naar HIVhelpdesk@who.int
Misschien kunnen we iemand van die organisatie interviewen

Belangrijkste info uit het artikel:

Oplossingen voor de toekomst

• Finalizing the results of ongoing technical assistance to the government in developing key normative documents, including a National Strategy on HIV/AIDS, a National HIV/AIDS Treatment Plan and standards of HIV/AIDS treatment and care for different levels of the health care system (primary, secondary and tertiary) and finalizing guidelines on treatment to be consistent with
evidence-based recommendations from WHO

• Developing and supporting a strategic approach for further reducing antiretroviral drug prices, including continued negotiations on drug prices with pharmaceutical companies and registering generic antiretroviral drugs

• Providing technical support for establishing regional centres of excellence in building human resource capacity for scaling up antiretroviral therapy and expanding to the Russian Federation the treatment and care activities of the Knowledge Hub for the Care and Treatment of HIV/AIDS in Eurasia

• Assisting in developing models of HIV testing and counselling and antiretroviral therapy delivery for vulnerable populations, including injecting drug users, sex workers and prisoners

• Assisting in the establishment of service delivery links between HIV/AIDS and tuberculosis, sexually transmitted infections, maternity, prison and other prevention and care services in order to enhance treatment entry, adherence and follow-up, especially for vulnerable populations

• Providing evidence for and advocating for expanding harm reduction activities for injecting drug users (including needle and syringe exchange) as well as introducing substitution treatment to enhance entry into treatment and adherence to antiretroviral therapy

• Assisting in developing a plan for procuring and managing the supply of antiretroviral drugs and HIV/AIDS diagnostics

• Developing indicators and methods and strengthening the data collection systems and skills for the surveillance of treatment and care outcomes (including monitoring people living with HIV/AIDS receiving antiretroviral therapy and patterns of antiretroviral drug resistance) and introducing second-generation surveillance

• Providing assistance for developing strategies for further HIV/AIDS operational research

• Supporting the development of a national HIV/AIDS treatment and care plan in the context of striving to achieve universal access

http://www.who.int/hiv/HIVCP_RUS.pdf